AI Latest News : Tech Lens MediaTech Lens Media
AI Latest News : Tech Lens MediaTech Lens Media
Home
AI In Action
Startup FundingFundingEnterprise AIAI AgentsAIAI Infrastructure
AI ToolsAI AgenciesEvents
List Your AI Agency
HomeAI In ActionAI ToolsAI AgenciesEvents
List Your AI Agency
AI Latest News : Tech Lens MediaTech Lens Media

Source-backed AI news, funding intelligence and discovery across tools, companies and emerging technology.

© 2026 Tech Lens Media. All rights reserved.

Categories

  • Startup Funding
  • Funding
  • Enterprise AI
  • AI Agents
  • AI
  • AI Infrastructure
  • DeepTech

Company

  • About Us
  • Terms and Condition
  • Privacy Policy
  • Disclaimer
  • AI Information
  • Contact Us
  • Sitemap
  • RSS Feed

Follow us

HomeNewsAisel Raises €1.7M for AI-Powered Psychiatry Workflows

Aisel Raises €1.7M for AI-Powered Psychiatry Workflows

H. Sureja
•
August 20, 2026
•
2 mins read
AI HealthcareAdd as a preferred
source on Google
Share Article:

Image credit : Tech.eu

Share

Aisel is building for one of psychiatry’s least visible capacity problems: clinicians can spend valuable time reconstructing patient histories, reviewing referrals and completing documentation instead of seeing more patients. The company has built a psychiatry-specific AI platform designed to carry that administrative workload across the full consultation journey, from intake and preparation to clinical notes and follow-up.

The company has raised €1.7 million in pre-seed funding led by Caesar Ventures, with participation from Nordic Web Ventures, LifeX and AngelInvest, alongside existing investors Rockstart and EIFO. The new capital will support Aisel’s entry into the UK and expand its clinical and engineering teams as it works with psychiatrists across Northern Europe.

Aisel is led by co-founder and CEO Augusta Klingsten Peytz and co-founder and Chief Product Officer Christian Houen. Augusto Klingsten Peytz’s route into mental-health technology began after experiencing healthcare pressure personally and later working in mental-health investing. The company has since built its product alongside practicing psychiatrists, with the stated goal of reducing waiting times by giving scarce clinical specialists more time for judgment and patient care.

Its technology goes further than an AI scribe. Aisel can prepare clinicians before appointments by pulling together years of referrals, notes and intake data, then structure information during the consultation and draft records for review afterward. It also supports adaptive intake, source-linked document generation, billing codes and EHR synchronization, while keeping clinician review at decision points.

That distinction matters in psychiatry, where the problem is rarely just writing faster. Clinicians need context spread across long records, repeated visits and complex documentation. Aisel is betting that the more valuable AI system is the one that helps preserve that context throughout the patient journey.

The next test is whether removing enough administrative friction can translate into something healthcare systems urgently need: more psychiatric capacity without asking clinicians to work longer hours.

AI HealthcareAiselHealthTechPsychiatryStartup FundingWorkflow Automation

Trending News

Trending News

RELATED STORIES

More from AI Healthcare

Tandem Health Raises $100M After AI Notes Exposed a Bigger Problem

Tandem Health Raises $100M After AI Notes Exposed a Bigger Problem

During an AI trial at St Wulfstan’s Surgery in Warwickshire, one patient noticed something that had little to do with software: the doctor was looking at them instead of the computer. “Listening rather than typing was very positive,” the patient said. Clinicians in the trial spent 16.7% of consultations looking at a computer when using […]

H. SurejaSeptember 15, 2026
Scan.com Raises $220M to Expand U.S. Medical Imaging Infrastructure

Scan.com Raises $220M to Expand U.S. Medical Imaging Infrastructure

A medical scan can take less than an hour. Reaching the scanner can take weeks. That gap is what Scan.com has spent nearly a decade trying to remove. The company began in the UK in 2017, after clinicians Dr Khalid Latief and Jasper Nissim saw how slow and opaque diagnostic imaging could be for their […]

H. SurejaSeptember 2, 2026
Remepy Raises $36M to Advance Hybrid Drugs Into Phase III

Remepy Raises $36M to Advance Hybrid Drugs Into Phase III

Modern medicine can be remarkably precise about what happens inside the body, yet much of what shapes recovery happens outside the pill. Movement, cognition, behavior and daily routines can influence how patients manage chronic disease, but those interventions often sit in separate programs, appointments and apps. Remepy is building around a different idea: what if […]

H. SurejaAugust 13, 2026